Noiruimunbaiotekku
4893.TTSE GROWTHPharmaceutical
Filed as Noile-Immune Biotech Inc. (2023-08–2026-08)
In English · 3
Fri, Oct 9 · JST1 filing
09:245% STAKENoiruimunbaiotekku · OKASAN SECURITIES CO., LTD. · 19.29%new 19.29%Wed, Jul 31 · JST1 filing
16:055% STAKENoiruimunbaiotekku · TSURUKAME CO., LTD + 2 joint holders · 21.90% → 20.63%−1.27ppFri, Jul 26 · JST1 filing
16:055% STAKENoiruimunbaiotekku · TSURUKAME CO., LTD + 2 joint holders · 25.14% → 21.90%−3.24ppAll EDINET filings · 40
| Filed | Document | Source |
|---|---|---|
| 2026-08-13 | Half-year report | S100YWIQ |
| 2026-03-23 | Annual report | S100XSP4 |
| 2025-08-08 | Half-year report | S100WI8E |
| 2025-03-28 | Annual report | S100VIKJ |
| 2024-10-15 | Amended half-year reportAmends S100U7Q7 | S100UJB3 |
| 2024-08-13 | Half-year report | S100U7Q7 |
| 2024-05-14 | Quarterly report | S100TFAS |
| 2024-03-29 | Annual report | S100T6PI |
| 2023-11-13 | Quarterly report | S100S9G1 |
| 2023-08-14 | Quarterly report | S100RP80 |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected.